talent · /frederick

David Frederick

Built HC21 UK from zero in 2012 to c.EUR70m by exit as UK MD; earlier Covidien VP Sales EMEA (£700m sales org).
Outreach drafts on file (1)
tom as partner → founder
Healthcare 21 UK: Aquilant, Xograph, Cardio Solutions, and a medtech question
draft #165 · 2026-09-17 03:47 UTC
Open draft →

Identity spine

Age: 60 · Location: UK · Frame: divisional MD (HC21 rebuild team) · Judge tier: 1b · Judge Focus-44 rank: 16

Current role

NED Healthcare 21 (2023-); ex-UK MD HC21; ex-Covidien VP Sales EMEA (£700m sales org)
_Company: HC21 NED role; ex-Covidien._

Previous role (signature)

Built HC21 UK from zero in 2012 to c.EUR70m by exit as UK MD; earlier Covidien VP Sales EMEA (£700m sales org).

Built HC21 UK from zero (2012) to c.EUR70m by exit as UK MD; earlier Covidien VP Sales EMEA (£700m sales org); free since Apr-2023.

INSITE PRIMARY-SOURCE NAMED at ev 5749: "David Fredericks (ex-Covidien) built HC21 UK from zero" per l4-addlife.md corpus. HC21 was AddLife 2016 Addtech carve-out + Aquilant UK/Ireland roll-up. Fluent by construction in Addtech-lineage acquisition machinery.

Availability

AVAILABLE_NOW (NED-drift caveat)

Outreach window: APPROACH NOW; pair with Kearney

Warm-intro nodes

Pair with Kearney via Owen Curtin / PwC; confirm HC21 NED status first.

Character read

divisional MD (HC21 rebuild team) · AddLife/Nordic-compounder · L4 bracket STRONG · L1=1 L2=4 L4=3 L5=4 L6=3

Path to seat: corporate_vp_to_startup_country_md

Sensitive next-conversation questions

Data gap: Deal-origination-as-principal weak; NED-drift risk at 60.

Sources

  1. Judge Focus-44 v2 (2026-09-16)
  2. Judge Focus-44 v2
  3. Judge Focus-44 v2 · peak_professional
  4. Judge Focus-44 v2 · anchor_opener_fact
  5. Judge Focus-44 v2 · availability
  6. Judge Focus-44 v2 · outreach_window
  7. Judge Focus-44 v2 · warm_intro_route
  8. Judge Focus-44 v2 · judge_why
  9. Judge Focus-44 v2 · path_to_seat
  10. Judge Focus-44 v2 · data_gaps
view.ukacq.com/frederick · all cards · draft